Profile data is unavailable for this security.
About the company
Transcenta Holding Ltd is a investment holding company engaged in the discovery, research, development, manufacturing and business development of biopharmaceuticals in the clinical stage. The Company's products include MSB2311, TST001, TST005, TST002, TST004, TST003, TST008, MSB0254 and TST006. The Company also provides contract development and manufacturing organization (CDMO) services, mainly including process development services, GMP / cGMP production services, cell line development services, sample testing services, formula optimization services and drug formation research.
- Revenue in HKD (TTM)12.31m
- Net income in HKD-317.40m
- Incorporated2010
- Employees184.00
- LocationTranscenta Holding LtdB6-501, Biobay, 218 Xinghu StreetSUZHOU 215123ChinaCHN
- Websitehttps://www.transcenta.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China NT Pharma Group Co Ltd | 41.50m | -58.34m | 424.78m | 22.00 | -- | -- | -- | 10.23 | -0.1886 | -0.1886 | 0.1572 | -1.65 | 0.1145 | 389.29 | 7.55 | 1,886,581.00 | -16.09 | -10.31 | -- | -- | 13.86 | -- | -140.56 | -97.11 | 0.0221 | -0.7071 | -- | -- | 415.34 | -24.38 | -59.32 | -- | -71.03 | -- |
| Modern Chinese Medicine Group Co Ltd | 234.06m | 10.57m | 540.00m | 190.00 | 42.55 | 0.85 | 26.25 | 2.31 | 0.0176 | 0.0176 | 0.3901 | 0.8824 | 0.4006 | 4.13 | 2.23 | 1,231,885.00 | 1.81 | 14.83 | 1.99 | 17.56 | 25.78 | 38.44 | 4.52 | 17.92 | 6.58 | 48.29 | 0.0003 | 2.85 | -37.78 | -0.4333 | -80.18 | -26.87 | 112.81 | -- |
| Uni-Bio Science Group Ltd | 552.98m | 82.77m | 698.63m | 487.00 | 8.70 | 2.15 | 6.71 | 1.26 | 0.0135 | 0.0135 | 0.0901 | 0.0545 | 1.19 | 2.62 | 12.27 | 1,135,483.00 | 17.85 | 6.21 | 24.02 | 8.56 | 83.38 | 80.72 | 14.97 | 4.96 | 2.31 | 77.61 | 0.2613 | 1,633.58 | 14.08 | 21.43 | 16.79 | 102.04 | 32.65 | -- |
| Zhongzhi Pharmaceutical Holdings Ltd | 2.42bn | 104.10m | 734.06m | 2.58k | 6.91 | 0.6013 | 3.26 | 0.3031 | 0.123 | 0.123 | 2.86 | 1.41 | 1.17 | 2.73 | 8.71 | 939,699.00 | 5.09 | 6.77 | 7.91 | 10.47 | 58.35 | 59.64 | 4.34 | 5.91 | 0.9142 | 82.35 | 0.144 | 38.97 | 8.05 | 10.54 | -41.51 | -3.65 | 13.62 | 10.79 |
| Pak Fah Yeow International Ltd | 236.76m | 78.63m | 763.52m | 106.00 | 9.71 | 1.04 | 8.88 | 3.22 | 0.2522 | 0.2522 | 0.7594 | 2.35 | 0.2705 | 2.69 | 12.93 | 2,233,576.00 | 8.98 | 5.03 | 9.33 | 5.24 | 86.22 | 82.23 | 33.21 | 23.92 | 15.66 | 4.52 | 0.0057 | 94.02 | -8.64 | 9.89 | -25.14 | 16.88 | 16.37 | -8.84 |
| Transcenta Holding Ltd | 12.31m | -317.40m | 804.50m | 184.00 | -- | 0.914 | -- | 65.34 | -0.7842 | -0.7842 | 0.0304 | 2.02 | 0.0078 | 0.4204 | 0.4022 | 66,916.18 | -20.06 | -32.48 | -29.08 | -41.13 | 35.55 | 22.08 | -2,577.85 | -1,072.37 | 0.7675 | -812.03 | 0.25 | -- | -79.09 | -23.91 | 37.24 | -- | -60.12 | -- |
| Lee's Pharmaceutical Holdings Ltd | 1.40bn | 93.10m | 895.03m | 1.02k | 9.61 | 0.5419 | 4.39 | 0.6393 | 0.1581 | 0.1581 | 2.38 | 2.81 | 0.5083 | 2.21 | 11.40 | 1,369,833.00 | 2.49 | 13.85 | 3.21 | 18.24 | 53.81 | 59.37 | 4.90 | 35.22 | 0.6445 | 8.96 | 0.128 | 2.97 | 32.95 | 2.81 | 457.55 | -5.81 | -10.46 | -4.28 |
| Meilleure Health Intrntnl Indu Grp Ltd | 50.68m | 32.48m | 1.19bn | 46.00 | 36.52 | 0.9877 | -- | 23.43 | 0.0079 | 0.0079 | 0.0124 | 0.2936 | 0.0301 | 0.0831 | 0.9562 | 1,101,652.00 | 1.90 | 2.74 | 2.15 | 3.02 | 57.04 | 47.18 | 63.24 | 28.59 | 2.72 | -- | 0.2015 | 41.83 | -60.81 | -26.41 | -20.45 | -- | -1.03 | -- |
| Cryofocus Medtech Shanghai Co Ltd | 58.53m | -114.11m | 1.19bn | 276.00 | -- | 14.78 | -- | 20.39 | -0.4772 | -0.4772 | 0.2448 | 0.3377 | 0.2957 | 0.5577 | -- | 212,064.60 | -61.47 | -- | -87.48 | -- | 71.75 | -- | -207.87 | -- | 1.14 | -- | 0.3544 | -- | 30.72 | -- | -7.06 | -- | -- | -- |
Data as of Jul 18 2025. Currency figures normalised to Transcenta Holding Ltd's reporting currency: Hong Kong Dollar HKD
5.96%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fullerton Fund Management Co. Ltd.as of 31 Dec 2023 | 26.02m | 5.96% |
Data from 31 Mar 2025 - 31 Mar 2025Source: FactSet Research Systems Inc.
